AstraZeneca Pledges $14.2B in China to Boost Innovation Ecosystem
AstraZeneca CEO announces $14.2B investment in China, highlighting the country’s critical role in global pharmaceutical innovation and production.
PharmaInnovation
Read More
Cuba Showcases Biotech Innovations at Shanghai’s CIIE Expo
Cuba highlights its biotechnology and pharmaceutical sectors at Shanghai’s International Import Expo, joining 4,000+ global exhibitors to foster trade ties.
China’s Ivonescimab Outperforms Keytruda in Late-Stage Cancer Trials
Chinese-developed cancer drug Ivonescimab surpasses Keytruda in Phase III trials, signaling potential shift in global oncology treatment standards.